InvestorsHub Logo
Followers 9
Posts 152
Boards Moderated 0
Alias Born 01/10/2022

Re: misiu143 post# 209526

Friday, 05/27/2022 7:44:25 AM

Friday, May 27, 2022 7:44:25 AM

Post# of 233147
Yep. That distinguished leronlimab from other immunomodulators - even dex. There was no way to know, though, until they got the lab results. A big bounce back or a large build up of sequester drug in the body could have done more harm than good. Their proposed MOA elevated the need for reliable safety and lab data right at the time it became apparent it wasn't all being made available to the FDA or even the sponsor. It was a bad situation in a time of heightened tension and fear. We'll get there. We would have gotten there sooner without the paranoid shorts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News